Validating Transgenic Farmington Viruses for the Treatment of Glioblastoma Multiforme
Glioblastoma is the most common primary brain tumour in adults. Despite the aggressive standard of care currently used, median patient survival following treatment is only 14 months. Innovative treatment options are needed for these patients. Recently, oncolytic viruses have emerged as promising imm...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
Université d'Ottawa / University of Ottawa
2015
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10393/33354 http://dx.doi.org/10.20381/ruor-4042 |